le (19m4s)
Résultats de recherche
le (12m26s)
Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Non-inferiority, superiority, or both? Operationalizing the FDA guidance
... DUNDER, EMEA, SWEAbstract : The evaluation of cardiovascular safety of rosiglitazone (2006-2010) had implications on regulatory guidance for glucose lowering drugs both in the EU and in the US and both the FDA and the CHMP guidelines for development of... Voir la vidéole (10m40s)
Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Non-inferiority, superiority, or both? Operationalizing the FDA guidance (debates).
...Title : Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : <br>Non-inferiority, superiority, or both? Operationalizing the FDA guidance (debates).Speaker: Marc PFEFFER, Boston, USADiscussant: Stuart POCOCK, London,... Voir la vidéole (15m47s)
Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Non-inferiority, superiority, or both? Operationalizing the FDA guidance
Title: Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Non-inferiority, superiority, or both? Operationalizing the FDA guidanceSpeaker: Marc PFEFFER, Boston, USADiscussant: Stuart POCOCK, London, GBRRegulatory viewpoint: Kristina DUNDER, EMEA, SWEAbstract : Non-inferiority, superiority, or both? Operationalizing the FDA guidanceL’auteur n’a pas transmis de conflit d’intérêt concernant les données diffusées dans cette vidéo ou publiées dans la référence citée.Conférence enregistrée : 9th Global Cardiovascular Clinical Trialists Forum • Paris 2012 Diabetes clinical trials : helped or hindered by the current shift in regulatory requirements? Glycaemic control is an inadequate surrogate marker of cardiovascular event reduction in patients with type 2 diabetes. Clinical ... Voir la vidéole (5m0s)
Percutaneous nephrolothotomy: the easy puncture
... sufficient for proper needle guidance : With a patient in the prone position, and a ureteral catheter inserted, a vertical beam gives very good information on calyx geography. However, when the needle is super-imposed to the calyx on the screen if the needle... Voir la vidéole (9m19s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Impact of major clinical trials on ESC Chronic Heart Failure 2012 guidelines. Game changer trials: EMPHASIS-HF, SHIFT, Devices…
... also important, differences in recommendations may act as a barrier to guideline. The NICE CHF guidance was updated in 2010, and it is not likely to be revised in short term.Practice differs from the guideline recommendations. Registries suggest... Voir la vidéole (13m12s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Impact of major clinical trials on ESC Chronic Heart Failure 2012 guidelines. Game changer trials: EMPHASIS-HF, SHIFT, Devices…(debates).
... is also important, differences in recommendations may act as a barrier to guideline. The NICE CHF guidance was updated in 2010, and it is not likely to be revised in short term.Practice differs from the guideline recommendations. Registries suggest... Voir la vidéole (13m57s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : National guideline implementation and national registries.
... is also important, differences in recommendations may act as a barrier to guideline. The NICE CHF guidance was updated in 2010, and it is not likely to be revised in short term.Practice differs from the guideline recommendations. Registries suggest... Voir la vidéole (26m16s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Compound vs. class effect. Drug class recommendations in guidelines
... differences in recommendations may act as a barrier to guideline. The NICE CHF guidance was updated in 2010, and it is not likely to be revised in short term.Practice differs from the guideline recommendations. Registries suggest differences in guideline... Voir la vidéole (37m35s)


